首页 > 市场调查报告书 > 製药

基因治疗学和RNAi 再生医学细胞疗法基因疗法

南美洲和中美洲细胞和基因治疗製造服务市场预测至 2030 年 - 区域分析 - 按类型、适应症（癌症、骨科等）、应用（临床製造和商业製造）和最终用户

市场调查报告书

商品编码

1452635

南美洲和中美洲细胞和基因治疗製造服务市场预测至 2030 年 - 区域分析 - 按类型、适应症（癌症、骨科等）、应用（临床製造和商业製造）和最终用户

South & Central America Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type, Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User

出版日期: 2024年01月15日 | 出版商:

The Insight Partners | 英文 92 Pages | 订单完成后即时交付

价格

简介目录图表

南美洲和中美洲细胞和基因治疗製造服务市场预计将从2022年的2.8683亿美元增长到2030年的9.8118亿美元。预计2022年至2030年CAGR为16.6%。

外包细胞和基因治疗製造的日益普及推动了南美洲和中美洲细胞和基因治疗製造服务市场

细胞和基因疗法的製造是一个复杂的过程，这使得正确执行和监督操作至关重要。细胞和基因治疗製造商了解生物和製程工程的合格人员数量有限。此外，对于经验丰富的团队来说，使用手动和开放製造方法来管理首次临床试验的尝试，然后建立更适合商业的流程可能会很棘手。因此，这些企业选择与合约开发和製造组织（CDMO）合作来加速其临床研究和商业化进程。 CDMO 以合约形式向细胞和基因治疗公司提供产品开发、製造、临床试验支援和商业化服务。与 CDMO 合作可以帮助细胞和基因疗法製造商实现可扩展性、加快上市速度、无需管理成本即可获得技术专业知识以及成本效率。此外，2020年3月，Fujifilm Cellular Dynamics（FCDI）投资2,100万美元建造符合cGMP的生产设施，该设施将用于製造FCDI使用诱导多能干细胞（iPSC）的再生医学疗法的管道并提供CDMO服务用于生产iPSC 和iPSC 衍生的分化细胞。事实证明，将细胞和基因治疗製造外包给 CDMO 对于製造商来说具有成本效益。此外，他们还可以获得 CDMO 技术先进的基础设施和专业知识。 CDMO 采用适当的、映射的流程来製造细胞和基因疗法。因此，越来越倾向于将不断增长的细胞和基因治疗製造外包给 CDMO，推动了南美洲和中美洲细胞和基因治疗製造服务市场的成长。

南美洲和中美洲细胞和基因治疗製造服务市场概述

《法律商业研究2020》发表的题为《巴西批准首个基因治疗产品》的报告显示，巴西是拉丁美洲家中第一个批准销售基因治疗产品的国家。具体来说，巴西卫生监管局（ANVISA）授予诺华基因治疗产品Luxturna和Zolgensma的上市许可。这两款产品均获得了巴西生物安全技术委员会（CTNBio）的批准，该委员会负责评估巴西基因改造生物的生物安全性。根据 Clinical Trials Arena 的数据，2021 年，巴西占全球临床试验活动的 1.7% 份额。 2022 年 7 月，波士顿 CRO 收购了位于里约热内卢的 Instituto Brasil de Pesquisa Clinica (IBPClin)，并将其描述为在拉丁美洲采用分散式临床试验交付模式的第一步。该公司声称已开展了 160 多项行业资助的研究，在巴西 12 个州招募了 7,000 多名参与者。

南美洲和中美洲细胞和基因治疗製造服务市场收入及 2030 年预测（百万美元）

南美洲和中美洲细胞和基因治疗製造服务市场细分

南美洲和中美洲细胞和基因治疗製造服务市场分为类型、适应症、应用、最终用户和国家。

根据类型，南美洲和中美洲细胞和基因治疗製造服务市场分为细胞治疗和基因治疗。 2022年，细胞治疗领域在南美洲和中美洲细胞和基因治疗製造服务市场中占据更大份额。细胞治疗部分进一步分为自体细胞治疗和同种异体细胞治疗。基因治疗部分进一步细分为病毒载体和非病毒载体。

根据迹象，南美洲和中美洲细胞和基因治疗製造服务市场分为癌症、骨科等。 2022年，癌症领域在南美洲和中美洲细胞和基因治疗製造服务市场中占据最大份额。

根据应用，南美洲和中美洲细胞和基因治疗製造服务市场分为临床製造和商业製造。 2022年，商业製造领域在南美洲和中美洲细胞和基因治疗製造服务市场中占据最大份额。

根据最终用户，南美洲和中美洲细胞和基因治疗製造服务市场分为製药和生物技术公司和合约研究组织（CRO）。 2022年，製药和生物技术公司部门在南美洲和中美洲细胞和基因治疗製造服务市场中占据更大份额。

根据国家/地区，南美洲和中美洲细胞和基因治疗製造服务市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022年，巴西在南美洲和中美洲细胞和基因治疗製造服务市场中占据最大份额。

Catalent Inc、Charles River Laboratories International Inc、Lonza Group AG、Merck KgaA、Nikon Corp、Takara Bio Inc 和 Thermo Fisher Scientific Inc 是南美洲和中美洲细胞和基因治疗製造服务市场的一些领先公司。

Cell and gene therapy manufacturing is a complex process, which makes the proper execution and overseeing of the operation crucial. Cell and gene therapy manufacturers have a limited number of qualified personnel who know biological and process engineering. Moreover, for experienced teams, managing the attempts to reach the first clinical trial using a manual, and open manufacturing method and then building a more commercially suitable process can be tricky. Therefore, these enterprises choose to work with contract development and manufacturing organizations (CDMOs) to accelerate their clinical studies and commercialization process. CDMOs provide product development, manufacturing, clinical trial support, and commercialization services to cell and gene therapy companies on a contract basis. Partnering with a CDMO enables scalability, speed to market, access to technical expertise without overhead costs, and cost efficiencies for cell and gene therapy manufacturers. Further, in March 2020, Fujifilm Cellular Dynamics (FCDI) invested US$ 21 million in the cGMP-compliant production facility, which would be used for manufacturing FCDI's pipeline of regenerative medicine therapies using induced pluripotent stem cells (iPSCs) and to provide CDMO services for production of iPSCs and iPSC-derived differentiated cells. Outsourcing cell and gene therapy manufacturing to CDMOs proves cost-effective for manufacturers. Moreover, they gain access to the technologically advanced infrastructure and expertise of CDMOs. CDMOs employ proper, mapped processes for manufacturing cell and gene therapies. Thus, the increasing preference for outsourcing growing cell and gene therapy manufacturing to CDMOs fuels the South & Central America cell and gene therapy manufacturing services market growth.

South & Central America Cell and Gene Therapy Manufacturing Services Market Overview

According to a report titled "First Gene Therapy Products Approved in Brazil," published by Law Business Research 2020, Brazil is the first among the Latin American countries to approve the marketing of gene therapy products. Specifically, the Brazilian Health Regulatory Agency (ANVISA) granted marketing authorization for Novartis' gene therapy products Luxturna and Zolgensma. Both products have been approved by the Brazilian Technical Commission of Biosafety (CTNBio), which is responsible for evaluating the biosafety of genetically modified organisms in Brazil. According to Clinical Trials Arena, in 2021, Brazil accounted for a 1.7% share of the global clinical trials activity. In July 2022, Boston CRO acquired Rio de Janeiro-based Instituto Brasil de Pesquisa Clinica (IBPClin), describing it as the first step toward adopting its decentralized clinical trial delivery model in Latin America. It claims to have conducted more than 160 industry-sponsored research studies, enrolling more than 7,000 participants across 12 Brazilian states.

South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Cell and Gene Therapy Manufacturing Services Market Segmentation

The South & Central America cell and gene therapy manufacturing services market is segmented into type, indication, application, end user, and country.

Based on type, the South & Central America cell and gene therapy manufacturing services market is bifurcated into cell therapy and gene therapy. In 2022, the cell therapy segment registered a larger share in the South & Central America cell and gene therapy manufacturing services market. The cell therapy segment is further segmented into autologous and allogenic. The gene therapy segment is further segmented into viral and non-viral vector.

Based on indication, the South & Central America cell and gene therapy manufacturing services market is segmented into cancer, orthopedics, and others. In 2022, the cancer segment registered the largest share in the South & Central America cell and gene therapy manufacturing services market.

Based on application, the South & Central America cell and gene therapy manufacturing services market is segmented into clinical manufacturing and commercial manufacturing. In 2022, the commercial manufacturing segment registered the largest share in the South & Central America cell and gene therapy manufacturing services market.

Based on end user, the South & Central America cell and gene therapy manufacturing services market is bifurcated into pharmaceutical and biotechnology companies and contract research organization (CROs). In 2022, the pharmaceutical and biotechnology companies segment registered a larger share in the South & Central America cell and gene therapy manufacturing services market.

Based on country, the South & Central America cell and gene therapy manufacturing services market is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2022, Brazil registered the largest share in the South & Central America cell and gene therapy manufacturing services market.

Catalent Inc, Charles River Laboratories International Inc, Lonza Group AG, Merck KgaA, Nikon Corp, Takara Bio Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America cell and gene therapy manufacturing services market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Cell and Gene Therapy Manufacturing Services Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increase in Number of Approval of Cell and Gene Therapies
- 4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
4.2 Market Restraints
- 4.2.1 High Cost of Cell and Gene Therapy Manufacturing
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Companies
4.4 Future Trends
- 4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
4.5 Impact Analysis:

5. Cell and Gene Therapy Manufacturing Services Market - South & Central America Market Analysis

5.1 South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - by Type

6.1 Overview
6.2 South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Cell Therapy
- 6.3.1 Overview
- 6.3.2 Cell Therapy: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.1 Autologous
    - 6.3.2.1.1 Overview
    - 6.3.2.1.2 Autologous: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.2 Allogenic
    - 6.3.2.2.1 Overview
    - 6.3.2.2.2 Allogenic: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Gene Therapy
- 6.4.1 Overview
- 6.4.2 Gene Therapy: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.4.2.1 Viral Vector
    - 6.4.2.1.1 Overview
    - 6.4.2.1.2 Viral Vector: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.4.2.2 Non-Viral Vector
    - 6.4.2.2.1 Overview
    - 6.4.2.2.2 Non-Viral Vector: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Cell and Gene Therapy Manufacturing Services Market Analysis and Forecasts to 2030 - by Indication

7.1 Overview
7.2 South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication 2022 & 2030 (%)
7.3 Cancer
- 7.3.1 Overview
- 7.3.2 Cancer: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Orthopedics
- 7.4.1 Overview
- 7.4.2 Orthopedics: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Application 2022 & 2030 (%)
8.4 Clinical Manufacturing
- 8.4.1 Overview
- 8.4.2 Clinical Manufacturing: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Commercial Manufacturing
- 8.5.1 Overview
- 8.5.2 Commercial Manufacturing: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue Share, by End User 2022 & 2030 (%)
9.4 Pharmaceutical and Biotechnology Companies
- 9.4.1 Overview
- 9.4.2 Pharmaceutical & Biotechnology Companies: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Research Organizations (CROs)
- 9.5.1 Overview
- 9.5.2 Contract Research Organizations (CROs): South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Overview
- 10.1.1 South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Country, 2022 & 2030 (%)
  - 10.1.1.1 Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
    - 10.1.1.1.1.1 Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
    - 10.1.1.1.1.2 Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
    - 10.1.1.1.2 Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
    - 10.1.1.1.3 Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.1.4 Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.2 Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
    - 10.1.1.2.1.1 Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
    - 10.1.1.2.1.2 Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
    - 10.1.1.2.2 Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
    - 10.1.1.2.3 Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.2.4 Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.3 Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
    - 10.1.1.3.1.1 Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
    - 10.1.1.3.1.2 Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
    - 10.1.1.3.2 Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
    - 10.1.1.3.3 Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.3.4 Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)

11. South & Central America Cell and Gene Therapy Manufacturing Services Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in South & Central America Cell and Gene Therapy Manufacturing Services Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Thermo Fisher Scientific Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Merck KGaA
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Charles River Laboratories International Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Lonza Group AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Catalent Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Takara Bio Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Nikon Corp
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

简介目录图表

List Of Tables

Table 1. South & Central America Cell and Gene Therapy Manufacturing Services Market Segmentation
Table 2. Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
Table 3. Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
Table 4. Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
Table 5. Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
Table 6. Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
Table 7. Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
Table 8. Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
Table 9. Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
Table 10. Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
Table 11. Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
Table 12. Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
Table 13. Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
Table 14. Rest of South and Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
Table 15. Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
Table 16. Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
Table 17. Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
Table 18. Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
Table 19. Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
Table 20. Recent Organic Growth Strategies in South & Central America Cell and Gene Therapy Manufacturing Services Market
Table 21. Recent Inorganic Growth Strategies in the South & Central America Cell and Gene Therapy Manufacturing Services Market

List Of Figures

Figure 1. South & Central America Cell and Gene Therapy Manufacturing Services Market Segmentation, By Country
Figure 2. South & Central America Cell and Gene Therapy Manufacturing Services Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue (US$ Mn), 2022 - 2030
Figure 5. South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Type 2022 & 2030 (%)
Figure 6. Cell Therapy: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Autologous: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Allogenic: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Gene Therapy: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Viral Vector: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Non-Viral Vector: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. South & Central America Cell and Gene Therapy Manufacturing Services Market, by Indication 2022 & 2030 (%)
Figure 13. Cancer: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Orthopedics: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Application 2022 & 2030 (%)
Figure 17. Clinical Manufacturing: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Commercial Manufacturing: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. South & Central America Cell and Gene Therapy Manufacturing Services Market Revenue Share, by End User 2022 & 2030 (%)
Figure 20. Pharmaceutical & Biotechnology Companies: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Contract Research Organizations (CROs): South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Key Region - Revenue (2022) (US$ Million)
Figure 23. South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market, by Country, 2022 & 2030 (%)
Figure 24. Brazil: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Argentina: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Rest of South & Central America: South & Central America Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Growth Strategies in South & Central America Cell and Gene Therapy Manufacturing Services Market

02-2729-4219

+886-2-2729-4219

License/价格

南美洲和中美洲细胞和基因治疗製造服务市场预测至 2030 年 - 区域分析 - 按类型、适应症（癌症、骨科等）、应用（临床製造和商业製造）和最终用户

South & Central America Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type, Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User

目录

第 1 章：简介

第 2 章：执行摘要

第 3 章：研究方法

第 4 章：南美洲和中美洲细胞和基因治疗製造服务市场 - 主要产业动态

第 5 章：细胞和基因治疗製造服务市场 - 南美洲和中美洲市场分析

第 6 章：南美洲和中美洲细胞和基因治疗製造服务市场 - 收入和 2030 年预测 - 按类型

第 7 章：2030 年南美洲和中美洲细胞和基因治疗製造服务市场分析和预测 - 按迹象

第 8 章：南美洲和中美洲细胞和基因治疗製造服务市场 - 收入和 2030 年预测 -按应用

第 9 章：南美洲和中美洲细胞和基因治疗製造服务市场 - 收入和 2030 年预测 - 按最终用户

第 10 章：南美洲和中美洲细胞和基因治疗製造服务市场 - 收入和 2030 年预测 - 国家分析

第 11 章：南美洲和中美洲细胞和基因治疗製造服务市场 - 产业格局

第 12 章：公司简介

Table Of Contents